Greg Liposky, MBA, Senior Vice President of Commercial Manufacturing at Athersys will be chairing the day 2 session and giving a presentation at 10 AM ET titled “Establishing Long-Term Strategic Plans for Commercial Manufacturing of Allogeneic Cell Therapies”. The presentation will include an overview of Athersys, MultiStem- a novel therapy for the treatment of ischemic stroke, and discuss the factors to consider in planning for product commercialization, such as process scalability, process reliability and process reproducibility.